Zurueck zur Suche

Reporte zur Charge UJ918AD

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

9Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
WI 2 IL 1 ID 1 PA 1 NE 1 NV 1 CO 1 CA 1

VAERS 2473736

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge uj918ad

moderat
Staat
IL
Alter
76,0
Geschlecht
F
Eingang
10.10.2022
Impfdatum
07.10.2022
Beginn
07.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Myalgia Palpitations Pyrexia

Symptomtext

muscle pain, heart racing, fever

Weitere VAERSDATA-Felder
Praegender Schweregrund
Palpitations
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2493618

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ918AD

mild
Staat
ID
Alter
65,0
Geschlecht
M
Eingang
30.10.2022
Impfdatum
24.10.2022
Beginn
25.10.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Hypoaesthesia Pain in extremity

Symptomtext

PAIN IN RIGHT SHOULDER AND RIGHT ARM; NUMBNESS IN RIGHT HAND FINGERS

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
UNKNOWN
Aktuelle Erkrankungen
NO
Vorgeschichte
NO
Andere Medikamente
FLUZONE HD QUADRIVALENT
Allergien
NO
Vorherige Impfungen
-

VAERS 2473718

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ918AD

mild
Staat
PA
Alter
72,0
Geschlecht
F
Eingang
10.10.2022
Impfdatum
06.10.2022
Beginn
08.10.2022
Tage bis Beginn
2,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chiropractic Erythema Injection site pain Injection site swelling Injection site warmth

Symptomtext

LOCALIZED LEFT ARM REDNESS, SWELLING, PAIN, HEAT. ONSET 2 DAYS AFTER INJECTION. HAD CHIROPRACTIC MANIPULATION OF SHOULDERS AND ARMS 1 DAY AFTER INJECTION.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site pain
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
R AXILLARY TENDERNESS 9/12/22 RESOLVED WITH ICE
Vorgeschichte
CAD OSTEOPENIA GALLBLADDER DISEASE SEASONAL ALLERGIES PAROXYSMAL ATRIAL FIBRILLATION POSTERIOR VITREOUS DETACHMENT HYPERTENSION R BREAST PAIN CERVICAL SPONDYLOSIS GERD HIATAL HERNIA ZENKER'S DIVERTICULUM
Andere Medikamente
AMLODIPINE 5MG ASPIRIN 81MG CALCIUM 1200 + VITAMIN D3 CRANBERRY 500MG DESLORATADINE 5MG EVENING PRIMROSE OIL 500MG IBUPROFEN 600MG METOPROLOL SUCCINATE ER 100MG OMEGA 3 1000MG OMEPRAZOLE 20MG ZYFLAMEND 5MG BIORON ARNICA BIORON COLD CALM O
Allergien
CODEINE - RASH HYDROCHLOROTHIAZIDE - ARRHYTHMIA PENICILLIN - RASH BACTRIM - GI UPSET MACROBID - GI UPSET
Vorherige Impfungen
-

VAERS 2548548

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ918AD

gering
Staat
WI
Alter
65,0
Geschlecht
M
Eingang
03.01.2023
Impfdatum
-
Beginn
28.12.2022
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Poor quality product administered Product storage error

Symptomtext

fluzone high-dose quadrivalent was administered post excursion with no reported adverse events; Initial information received on 30-Dec-2022 regarding an unsolicited valid non-serious case received via pharmacist. This case involves a 65 years old male patient who was diagnosed with fluzone high-dose quadrivalent was administered post excursion with no reported adverse events after receiving vaccine influenza quadrival a-b high dose hv vaccine [Fluzone High-Dose Quadrivalent]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received suspect influenza quadrival a-b high dose hv vaccine at a dose of 0.5 ml (strength, frequency, formulation: unknown)(batch number: UJ918AD, Expiry date: 30-Jun-2023) via intramuscular route in unknown administration site for Immunization On 28-Dec-2022 the patient diagnosed with a non-serious event of fluzone high-dose quadrivalent was administered post excursion with no reported adverse events (poor quality product administered) (unknown latency) following the administration of influenza quadrival a-b high dose hv vaccine. Action taken was not applicable. At time of reporting, the outcome was Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2541552

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ918AD

gering
Staat
NE
Alter
68,0
Geschlecht
M
Eingang
23.12.2022
Impfdatum
12.12.2022
Beginn
12.12.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered Medication error No adverse event

Symptomtext

patient received 2 doses of the product fluzone HD QIV with no reported adverse event; Initial information received on 20-Dec-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 68 years old male patient who received 2 doses of the product influenza quadrival A-B high dose HV vaccine [Fluzone High-Dose Quadrivalent] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 12-Dec-2022, the patient received a second dose of suspect influenza quadrival A-B high dose HV vaccine at a dose of 0.7 ml once (lot UJ918AD and expiry date: 30-JUN-2023)(form and strength: unknown) via intramuscular route in the left deltoid for Immunization On 12-DEC-2022 the patient received 2 doses of the product fluzone hd qiv with no reported adverse event (extra dose administered) same day following the administration of influenza quadrival A-B high dose HV vaccine. Reportedly, patient received 2 doses of the product fluzone HD QIV and is calling to get guidance moving forward. Patient did not experience any adverse reactions. Patient received a dose o f FLUZONE HD QIV in their office last week on 12-DEC-2022. However, they did not realize that the patient had received a previous dose in Oct-2022. Action taken was not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2538506

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ918AD

gering
Staat
NV
Alter
91,0
Geschlecht
F
Eingang
20.12.2022
Impfdatum
08.12.2022
Beginn
09.12.2022
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Vision blurred

Symptomtext

Patient was given 2nd dose Shingrix and Pfizer booster dose on 12/03/22. On 12/8/22 she was given Fluzone HD. The next morning the patient was experiencing blurr vision in both eyes (worser on the right eye) which is still not resolved. Patient used cool and warm compress on the eyes and was given Restasis to help alleviate the problem by her optometrist which also not helping.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Vision blurred
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
NO
Vorgeschichte
EMPHYSEMA, HYPERTENSION, ANXIETY
Andere Medikamente
BLOOD PRESSURE, BREATHING INHALER, BENZODIAZEPINE
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2536178

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ918AD

gering
Staat
CO
Alter
64,0
Geschlecht
F
Eingang
18.12.2022
Impfdatum
27.09.2022
Beginn
27.09.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product administered to patient of inappropriate age

Symptomtext

Pt received HD Fluzone and was under the age of 65

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
n/a
Vorgeschichte
n/a
Andere Medikamente
n/a
Allergien
n/a
Vorherige Impfungen
-

VAERS 2505316

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ918AD

gering
Staat
WI
Alter
62,0
Geschlecht
M
Eingang
11.11.2022
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Medication error No adverse event Product administered to patient of inappropriate age

Symptomtext

patient was inadvertently given the fluzone hd, with no reported adverse event; Initial information received on 01-Nov-2022 regarding an unsolicited valid non-serious case from other health professional. This case involves a 62 year old male patient who was inadvertently given the Influenza Quadrival A-B High Dose HV Vaccine [Fluzone High-Dose Quadrivalent], with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication and family history were not provided. On an unknown date, the patient received suspect Influenza Quadrival A-B High Dose HV Vaccine at a dose of 0.7 ml (lot UJ918AD, expiry date: 30-Jun-2023) via intramuscular route in unknown administration site for immunization. On an unknown date the patient was inadvertently given the fluzone hd, with no reported adverse event (product administered to patient of inappropriate age) (same day latency). Action taken: Not applicable. Outcome: Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Medication error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2485817

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UJ918AD

gering
Staat
CA
Alter
32,0
Geschlecht
M
Eingang
21.10.2022
Impfdatum
01.10.2022
Beginn
20.10.2022
Tage bis Beginn
19,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product administered to patient of inappropriate age

Symptomtext

Staff pharmacist administered FLuzone HD to adult under 65 years old. Pt is only 32 years old at time of vaccine was given. Patient was notified on the same day. Patient is doing fine, no side effects at this time. Patient and family member ( dad) was advised to call pharmacy/ MD if patient experience any symptoms.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
n/a
Vorgeschichte
n/A
Andere Medikamente
n/a
Allergien
n/A
Vorherige Impfungen
-